Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report.

Seven patients with chronic or recurrent supraventricular tachyarrhythmias were selected for a trial of antazoline therapy because sinus rhythm or a controlled ventricular response could not be achieved with quinidine, procainamide, digitalis or propranolol. Sinus rhythm was established by either intravenous administration of antazoline or direct-current countershock, and has been maintained in all for 4 to 16 months by oral administration of antazoline. Side effects were minor. Antazoline is a sufficiently promising antiarrhythmic agent to warrant large-scale controlled studies.

[1]  E. Sowton,et al.  The use of beta-adrenergic receptor blocking drugs in dysrhythmias. , 1969, Progress in cardiovascular diseases.

[2]  J. Bigger,et al.  The use of procaine amide and lidocaine in the treatment of cardiac arrhythmias. , 1969, Progress in cardiovascular diseases.

[3]  L. Lemberg.  Recurrent ventricular fibrillation precipitated by quinidine , 1969 .

[4]  J. Seymour,et al.  Cardiac failure in patients with valvar heart disease after use of propranolol to control atrial fibrillation. , 1968, British medical journal.

[5]  S. Stephen.  Unwanted effects of propranolol. , 1966, The American journal of cardiology.

[6]  D. Nathan,et al.  Atrial flutter with 1:1 atrioventricular conduction precipitated by antazoline (antistine). , 1966, Israel journal of medical sciences.

[7]  N. I. Nissen,et al.  [ANTAZOLINE IN CARDIAC ARRHYTHMIAS]. , 1965, Nordisk Medicin.

[8]  E. W. Reynolds,et al.  A CLINICAL TRIAL OF ANTAZOLINE IN THE TREATMENT OF ARRHYTHMIAS. , 1964, The American journal of cardiology.

[9]  J. Cummings,et al.  Quinidine Syncope: Paroxysmal Ventricular Fibrillation Occurring during Treatment of Chronic Atrial Arrhythmias , 1964, Circulation.

[10]  L. Dreifus,et al.  Clinical and physiologic effects of antazoline, a new antiarrhythmic agent , 1963 .

[11]  L. Leon-Sotomayor.  A clinical evaluation of the antiarrhythmic properties of antazoline. , 1963, The American journal of cardiology.

[12]  L. Dreifus,et al.  Evaluation of the antiarrhythmic properties of antazoline. A preliminary study. , 1962, The American journal of cardiology.

[13]  M. Sokolow,et al.  The clinical pharmacology and use of quinidine in heart disease , 1961 .

[14]  N. K. Dutta.  Some pharmacological properties common to antihistamine compounds. , 1949, British journal of pharmacology and chemotherapy.

[15]  S. Bellet,et al.  Clinical disorders of the heart beat. , 1946, Clinics.